While tight junction disruption and transporter remodeling are well defined in AD, parallel investigations into PD remain underdeveloped, with fewer human studies examining tight junction protein loss or transporter dysfunction in relation to α-synuclein pathology [97,108]. This evidence concerns the gene SNCA and Parkinson disease.